Gilead Sciences (GILD) Fundamental Analysis: Revenue, Earnings & Valuation

2.56 / 10

Underperform

Fundamental assessment rates GILD as underperform, scoring only 2.6/10. Profit‑MV and Cash‑MV are positive, yet Revenue‑MV, Current‑assets turnover and gross margin are weak. Asset‑MV is below peers, indicating limited growth and heightened risk.

Analysis Checks(6/10)

Revenue-MV

Value-0.24

Score0/3

Weight29.11%

1M Return5.06%

Net cash flow from operating activities per share (YoY growth rate %)

Value-7.10

Score3/3

Weight17.04%

1M Return3.44%

Inventory turnover ratio

Value3.58

Score2/3

Weight-5.29%

1M Return-1.20%

Gross profit margin (%)

Value78.83

Score0/3

Weight-29.90%

1M Return-7.64%

Profit-MV

Value1.23

Score2/3

Weight35.12%

1M Return6.22%

Current assets turnover ratio

Value1.57

Score1/3

Weight-1.86%

1M Return-0.40%

Fixed assets turnover ratio

Value5.34

Score2/3

Weight-0.31%

1M Return-0.06%

Cost of sales ratio (%)

Value21.17

Score2/3

Weight-19.00%

1M Return-4.69%

Asset-MV

Value-0.55

Score1/3

Weight40.73%

1M Return6.82%

Cash-MV

Value0.36

Score2/3

Weight34.36%

1M Return6.03%

Is GILD fundamentally strong?

GILD scores 2.56/10 on fundamentals and holds a Premium valuation at present. Backed by its 40.66% ROE, 28.90% net margin, 20.17 P/E ratio, 7.59 P/B ratio, and 1700.00% earnings growth, these metrics solidify its Underperform investment rating.